多发性骨髓瘤中克隆进化的分子和免疫机制
Stefan Forster1,2, Ramin Radpour1,2, Adrian F Ochsenbein1,2
1Tumor Immunology, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
多发性骨髓瘤 (MM) 由血细胞的基因突变引起,导致耐治疗性疾病. 了解MM细胞与瘤微环境 (TME) 的相互作用是开发有效治疗的关键.
科学领域:
- 血液学恶性瘤是什么
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 多发性骨髓瘤 (MM) 是骨髓中的血细胞的癌症.
- 骨髓瘤的发展涉及早期的遗传突变和累积的染色体异常.
- 恶性血细胞由自身隐性信号和瘤微环境 (TME) 支持.
研究的目的:
- 审查驱动骨髓形成和MM进展的关键机制.
- 为了阐明MM细胞和TME之间的相互作用.
- 突出药物耐药性和新兴的耐火性MM治疗方法.
主要方法:
- 关于MM的分子机制的文献综述.
- 对自身隐性信号通路的分析.
- 检查TME相互作用和耐药性的研究.
主要成果:
- 早期的遗传突变开始了骨髓形成.
- TME成分促进MM细胞的增殖和存活.
- 药物耐药性是高级MM的重大挑战.
结论:
- 了解MM病原和TME相互作用对于新疗法至关重要.
- 准MM细胞-TME交叉声可能会克服治疗阻力.
- 新兴的临床试验疗法为耐药性MM患者提供了希望.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
相关概念视频
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Differentiation of Common Myeloid Progenitor Cells
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Cells of the Adaptive Immune Response
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
